• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

何时开始癌症筛查检查?

When to initiate cancer screening exam?

作者信息

Wu Dongfeng

机构信息

Department of Bioinformatics and Biostatistics, University of Louisville.

出版信息

Stat Interface. 2022;15(4):503-514. doi: 10.4310/21-sii716. Epub 2022 Mar 4.

DOI:10.4310/21-sii716
PMID:36051671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9432459/
Abstract

A probability method is developed to decide when to initiate cancer screening for asymptomatic individuals. The probability of incidence is a function of screening sensitivity, time duration in the disease-free state and sojourn time in the preclinical state; and it is monotonically increasing as time increases, given a person's current age. So a unique solution of the first screening time can be found by limiting this probability to a small value, such as 10% or 20%. That is, with 90% or 80% probability, one will not be a clinical incident case before the first exam. After this age is found, we can further estimate the lead time distribution and probability of over-diagnosis if one would be diagnosed with cancer at the first exam. Simulations were carried out under different scenarios; and the method was applied to two heavy smoker cohorts in the National Lung Screening Trial using low-dose computerized tomography. The method is applicable to other kinds of cancer screening. The predictive information can be used by physicians or individuals at risk to make informed decisions on when to initiate screening.

摘要

开发了一种概率方法来确定何时开始对无症状个体进行癌症筛查。发病率概率是筛查敏感性、无病状态持续时间和临床前状态停留时间的函数;在给定一个人当前年龄的情况下,随着时间的增加,它会单调增加。因此,通过将这个概率限制在一个较小的值,比如10%或20%,可以找到首次筛查时间的唯一解。也就是说,有90%或80%的概率,一个人在首次检查之前不会成为临床发病病例。找到这个年龄后,如果一个人在首次检查时被诊断出患有癌症,我们可以进一步估计提前期分布和过度诊断的概率。在不同场景下进行了模拟;该方法应用于国家肺部筛查试验中使用低剂量计算机断层扫描的两个重度吸烟者队列。该方法适用于其他类型的癌症筛查。医生或有风险的个体可以使用这些预测信息,以便就是否开始筛查做出明智的决定。

相似文献

1
When to initiate cancer screening exam?何时开始癌症筛查检查?
Stat Interface. 2022;15(4):503-514. doi: 10.4310/21-sii716. Epub 2022 Mar 4.
2
Sojourn time and lead time projection in lung cancer screening.肺癌筛查中的逗留时间和领先时间预测。
Lung Cancer. 2011 Jun;72(3):322-6. doi: 10.1016/j.lungcan.2010.10.010. Epub 2010 Nov 13.
3
Estimation of Preclinical State Onset Age and Sojourn Time for Heavy Smokers in Lung Cancer.重度吸烟者肺癌临床前期发病年龄及病程时间的估计
Stat Interface. 2022;15(3):349-358. doi: 10.4310/21-sii696.
4
Inference of Sojourn Time and Transition Density using the NLST X-ray Screening Data in Lung Cancer.利用国家肺癌筛查试验(NLST)的X线筛查数据推断肺癌的停留时间和转移密度
Med Res Arch. 2021 May;9(5). doi: 10.18103/mra.v9i5.2399. Epub 2021 May 25.
5
Inference of Onset Age of Preclinical State and Sojourn Time for Breast Cancer.乳腺癌临床前期发病年龄及停留时间的推断
Med Res Arch. 2022 Feb;10(2). doi: 10.18103/mra.v10i2.2665.
6
Estimation of Lead Time via Low-Dose CT in the National Lung Screening Trial.在国家肺癌筛查试验中通过低剂量CT评估提前期
J Healthc Inform Res. 2018 Jun 12;2(4):353-366. doi: 10.1007/s41666-018-0027-8. eCollection 2018 Dec.
7
Estimating age group-dependent sensitivity and mean sojourn time in colorectal cancer screening.估算结直肠癌筛查中年龄相关的敏感性和平均居留时间。
J Med Screen. 2019 Mar;26(1):19-25. doi: 10.1177/0969141318790775. Epub 2018 Sep 27.
8
Estimating key parameters in periodic breast cancer screening-application to the Canadian National Breast Screening Study data.估算周期性乳腺癌筛查中的关键参数-应用于加拿大国家乳腺癌筛查研究数据。
Cancer Epidemiol. 2010 Aug;34(4):429-33. doi: 10.1016/j.canep.2010.04.001.
9
10
Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom.对英国40至49岁女性因乳腺钼靶筛查导致的乳腺癌过度诊断进行建模。
Breast Cancer Res. 2012 Nov 29;14(6):R152. doi: 10.1186/bcr3365.

本文引用的文献

1
Estimation of Lead Time via Low-Dose CT in the National Lung Screening Trial.在国家肺癌筛查试验中通过低剂量CT评估提前期
J Healthc Inform Res. 2018 Jun 12;2(4):353-366. doi: 10.1007/s41666-018-0027-8. eCollection 2018 Dec.
2
Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening.美国 2018 年癌症筛查:对当前美国癌症协会指南和癌症筛查中当前问题的综述。
CA Cancer J Clin. 2018 Jul;68(4):297-316. doi: 10.3322/caac.21446. Epub 2018 May 30.
3
Low-Dose CT Scan for Lung Cancer Screening: Clinical and Coding Considerations.
低剂量 CT 扫描用于肺癌筛查:临床和编码注意事项。
Chest. 2017 Jul;152(1):204-209. doi: 10.1016/j.chest.2017.03.019. Epub 2017 Mar 21.
4
Bayesian lead time estimation for the Johns Hopkins Lung Project data.贝叶斯 Lead 时间估计在约翰霍普金斯肺计划数据中的应用。
J Epidemiol Glob Health. 2013 Sep;3(3):157-63. doi: 10.1016/j.jegh.2013.05.001. Epub 2013 Jun 14.
5
The lead time distribution when lifetime is subject to competing risks in cancer screening.癌症筛查中当生存期存在竞争风险时的提前期分布。
Int J Biostat. 2012;8(1). doi: 10.1515/1557-4679.1363.
6
Reduced lung-cancer mortality with low-dose computed tomographic screening.低剂量计算机断层扫描筛查可降低肺癌死亡率。
N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.
7
Sojourn time and lead time projection in lung cancer screening.肺癌筛查中的逗留时间和领先时间预测。
Lung Cancer. 2011 Jun;72(3):322-6. doi: 10.1016/j.lungcan.2010.10.010. Epub 2010 Nov 13.
8
The National Lung Screening Trial: overview and study design.国家肺癌筛查试验:概述与研究设计。
Radiology. 2011 Jan;258(1):243-53. doi: 10.1148/radiol.10091808. Epub 2010 Nov 2.
9
Bayesian inference for the lead time in periodic cancer screening.周期性癌症筛查中提前期的贝叶斯推断。
Biometrics. 2007 Sep;63(3):873-80. doi: 10.1111/j.1541-0420.2006.00732.x.
10
MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening.周期性筛查中年龄依赖性敏感性和转移概率的最大似然估计及贝叶斯推断
Biometrics. 2005 Dec;61(4):1056-63. doi: 10.1111/j.1541-0420.2005.00361.x.